GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Medtronic, Inc. (MDT) [hlAlert]

Rating:
Mkt Perform
MDT

Medtronic, Inc. (MDT) rated Mkt Perform with price target $38 by Morgan Keegan

Posted on: Wednesday,  Aug 24, 2011  8:25 AM ET by Morgan Keegan

Medtronic, Inc. (NYSE: MDT) rated
Mkt Perform with price target $38 by Morgan Keegan.

Medtronic, Inc. (Medtronic) is a global player in medical technology. The Company operates in seven segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control. Through these seven segments, the Company develops, manufactures and markets its medical devices in more than 120 countries. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose and throat conditions. The primary markets for products are the United States, Western Europe and Japan. In July 2008, it acquired Restore Medical, Inc. In November 2008, Medtronic acquired CryoCath Technologies Inc. In February 2009, it acquired Ablation Frontiers, Inc. and Ventor Technologies Ltd. In April 2009, Medtronic acquired CoreValve, Inc.

Since Morgan Keegan's founding 38 years ago, quality investment research has been a hallmark of the firm. Over the years, we have built our reputation by focusing on companies that have gone unnoticed by Wall Street. Today, our staff of senior equity analysts tracks more than 250 companies concentrated in ten industry sectors
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/24/2011 8:25 AM Hold
None
32.85 38.00
as of 12/30/2011
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/17/2011 8:25 AM Hold
None
38.81 43.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy